Cargando…
The Usefulness of CDX-2 for Differentiating Primary and Metastatic Ovarian Carcinoma: An Immunohistochemical Study Using a Tissue Microarray
Distinguishing primary ovarian carcinoma from metastatic carcinoma to the ovary is often difficult by histologic examination alone. Recently an immunohistochemical marker CDX-2 was found to be of considerable diagnostic value in establishing the gastrointestinal origin of metastatic tumors. The aim...
Autor principal: | Kim, Mi Jin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782162/ https://www.ncbi.nlm.nih.gov/pubmed/16100458 http://dx.doi.org/10.3346/jkms.2005.20.4.643 |
Ejemplares similares
-
Immunohistochemical Expression of CDX2 in Gastric Carcinoma
por: Sardar, Ahmed Avan, et al.
Publicado: (2022) -
Diagnostic and Prognostic Roles of CDX2 Immunohistochemical Expression in Colorectal Cancers
por: Choi, Hong Bae, et al.
Publicado: (2022) -
Analysis of the concordance of 20 immunohistochemical tissue markers in metastasectomy lesions in patients with metastatic renal cell carcinoma: A retrospective study using tissue microarray
por: Kim, Sung Han, et al.
Publicado: (2020) -
CDX2 immunostaining in primary and metastatic germ cell tumours of the testis
por: Oz Atalay, Fatma, et al.
Publicado: (2016) -
Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray
por: Lee, Ming, et al.
Publicado: (2021)